Sign in
NMTC Stock Price, Chart, Stats & News
NeuroOne Medical Technologies Corporation
Save
NeuroOne Medical Technologies Corporation (NMTC) does not currently pay a dividend.
9.70M
Market cap
–
Current P/E
–
Forward P/E
NMTC chart
Fundamentals
Gross margin | 54.87% |
Operating margin | -87.71% |
Pretax margin | -78.34% |
Net margin | -78.34% |
Effective tax rate | – |
ROA | -79.61% |
ROE | -119.92% |
D/E | 0.04x |
Interest coverage ratio | 23.54x |
NMTC valuation
P/E | – |
P/S | 4.27x |
P/B | 5.77x |
P/CF | -6.00x |
P/FCF | -5.94x |
P/OCF | -6.00x |
PEG | 0.05x |
EV multiple | -5.94x |
About
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures.
Similar securities
Based on sector and market capitalization
Report issue